BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33155069)

  • 1. Risk factor of mediastinal lymph node metastasis of Siewert type I and II esophagogastric junction carcinomas.
    Nishiwaki N; Noma K; Matsuda T; Maeda N; Tanabe S; Sakurama K; Shirakawa Y; Fujiwara T
    Langenbecks Arch Surg; 2020 Dec; 405(8):1101-1109. PubMed ID: 33155069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of mediastinal lymph node metastases from adenocarcinoma of the esophagogastric junction versus lower esophageal squamous cell carcinoma with involvement of the esophagogastric junction.
    Mine S; Watanabe M; Kumagai K; Okamura A; Yuda M; Hayami M; Yamashita K; Imamura Y; Ishizuka N
    Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30791046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mediastinal lymph node metastasis and recurrence in adenocarcinoma of the esophagogastric junction.
    Kurokawa Y; Hiki N; Yoshikawa T; Kishi K; Ito Y; Ohi M; Wada N; Takiguchi S; Mine S; Hasegawa S; Matsuda T; Takeuchi H
    Surgery; 2015 Mar; 157(3):551-5. PubMed ID: 25532434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological Characteristics and Prognostic Factors of Patients with Siewert Type II Esophagogastric Junction Carcinoma: A Retrospective Multicenter Study.
    Matsuda T; Kurokawa Y; Yoshikawa T; Kishi K; Misawa K; Ohi M; Mine S; Hiki N; Takeuchi H
    World J Surg; 2016 Jul; 40(7):1672-9. PubMed ID: 26928855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors.
    Mine S; Kurokawa Y; Takeuchi H; Kishi K; Ito Y; Ohi M; Matsuda T; Hamakawa T; Hasegawa S; Yoshikawa T; Hiki N
    Eur J Surg Oncol; 2015 Oct; 41(10):1348-53. PubMed ID: 26087995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Five-step maneuver of transthoracic single-port assisted laparoscopic lower mediastinal lymph node dissection for Siewert type Ⅱ adenocarcinoma of the esophagogastric junction].
    Luo SJ; Xiong WW; Chen Y; Li ZY; Li E; Zeng HP; Zheng YS; Luo LJ; Li J; Cui ZM; Wan J; Wang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Aug; 24(8):684-690. PubMed ID: 34412185
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
    Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the surgical treatment strategies for Siewert type II squamous cell carcinoma in the same area as esophagogastric junction carcinoma: data from a single Japanese high-volume cancer center.
    Yabusaki H; Nashimoto A; Matsuki A; Aizawa M
    Surg Today; 2014 Aug; 44(8):1522-8. PubMed ID: 24166133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of lymph node metastases in locally advanced adenocarcinomas of the esophagogastric junction (cT2-4): comparison between Siewert type I and selected Siewert type II tumors.
    Sakaki A; Kanamori J; Ishiyama K; Kurita D; Oguma J; Daiko H
    Langenbecks Arch Surg; 2020 Jun; 405(4):509-519. PubMed ID: 32514766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of Lymph Node Metastasis From Esophagogastric Junction Tumors: A Prospective Nationwide Multicenter Study.
    Kurokawa Y; Takeuchi H; Doki Y; Mine S; Terashima M; Yasuda T; Yoshida K; Daiko H; Sakuramoto S; Yoshikawa T; Kunisaki C; Seto Y; Tamura S; Shimokawa T; Sano T; Kitagawa Y
    Ann Surg; 2021 Jul; 274(1):120-127. PubMed ID: 31404008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors and Prognostic Impact of Mediastinal Lymph Node Metastases in Patients with Esophagogastric Junction Cancer.
    Shiraishi O; Yasuda T; Kato H; Iwama M; Hiraki Y; Yasuda A; Shinkai M; Kimura Y; Imano M
    Ann Surg Oncol; 2020 Oct; 27(11):4433-4440. PubMed ID: 32409967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node metastasis from cancer of the esophagogastric junction, and determination of the appropriate nodal dissection.
    Kakeji Y; Yamamoto M; Ito S; Sugiyama M; Egashira A; Saeki H; Morita M; Sakaguchi Y; Toh Y; Maehara Y
    Surg Today; 2012 Apr; 42(4):351-8. PubMed ID: 22245924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal surgical management for esophagogastric junction carcinoma.
    Matsuda T; Takeuchi H; Tsuwano S; Nakamura R; Takahashi T; Wada N; Kawakubo H; Saikawa Y; Omori T; Kitagawa Y
    Gen Thorac Cardiovasc Surg; 2014 Sep; 62(9):560-6. PubMed ID: 24570201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
    Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of the number of lymph nodes examined in node-negative Siewert type II esophagogastric junction adenocarcinoma.
    Wu XN; Liu CQ; Tian JY; Guo MF; Xu MQ
    Int J Surg; 2017 May; 41():6-11. PubMed ID: 28323156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma.
    Yamashita H; Seto Y; Sano T; Makuuchi H; Ando N; Sasako M;
    Gastric Cancer; 2017 Mar; 20(Suppl 1):69-83. PubMed ID: 27796514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of outcomes after surgery between adenocarcinoma of the esophagogastric junction and lower thoracic esophageal squamous cell cancer].
    Fu SJ; Fang WT; Mao T; Feng J; Gu ZT; Chen WH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Sep; 15(9):893-6. PubMed ID: 22990917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of risk factors of lymph node metastasis and prognosis of Siewert II/III adenocarcinoma of esophagogastric junction: A retrospective study.
    Huang Y; Zheng Z; Xu R; Zhang H; Yin J; Liu X; Zhang J; Chen G; Zhang Z
    Medicine (Baltimore); 2024 Mar; 103(9):e37289. PubMed ID: 38428860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.
    Wang JB; Lin MQ; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Zheng CH; Huang CM
    Eur J Surg Oncol; 2017 Dec; 43(12):2333-2340. PubMed ID: 28928013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal extent of lymph node dissection for Siewert type II esophagogastric junction carcinoma.
    Yamashita H; Katai H; Morita S; Saka M; Taniguchi H; Fukagawa T
    Ann Surg; 2011 Aug; 254(2):274-80. PubMed ID: 21772128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.